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Abstract
Background: A microarray study may select different differentially expressed gene sets because
of different selection criteria. For example, the fold-change and p-value are two commonly known
criteria to select differentially expressed genes under two experimental conditions. These two
selection criteria often result in incompatible selected gene sets. Also, in a two-factor, say,
treatment by time experiment, the investigator may be interested in one gene list that responds to
both treatment and time effects.
Results: We propose three layer ranking algorithms, point-admissible, line-admissible (convex),
and Pareto, to provide a preference gene list from multiple gene lists generated by different ranking
criteria. Using the public colon data as an example, the layer ranking algorithms are applied to the
three univariate ranking criteria, fold-change, p-value, and frequency of selections by the SVM-RFE
classifier. A simulation experiment shows that for experiments with small or moderate sample sizes
(less than 20 per group) and detecting a 4-fold change or less, the two-dimensional (p-value and
fold-change) convex layer ranking selects differentially expressed genes with generally lower FDR
and higher power than the standard p-value ranking. Three applications are presented. The first
application illustrates a use of the layer rankings to potentially improve predictive accuracy. The
second application illustrates an application to a two-factor experiment involving two dose levels
and two time points. The layer rankings are applied to selecting differentially expressed genes
relating to the dose and time effects. In the third application, the layer rankings are applied to a
benchmark data set consisting of three dilution concentrations to provide a ranking system from a
long list of differentially expressed genes generated from the three dilution concentrations.
Conclusion: The layer ranking algorithms are useful to help investigators in selecting the most
promising genes from multiple gene lists generated by different filter, normalization, or analysis
methods for various objectives.
Background
Recent advances in DNA microarray technology provide
exciting tools for studying the expression levels of thou-
sands of distinct genes simultaneously. A common data
analysis approach is to identify a subset of key genes from
the original gene set that express differentially under dif-
ferent experimental conditions with a goal to determine
the underlying relationship between samples and genes or
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cal functions or to predict specific biological or therapeu-
tic outcomes from the subset of key genes. Selection of
differentially expressed genes can be separated into two
steps. The first step is to calculate a discriminatory score
that will rank the genes in order of evidence of differential
expressions. The second step is to determine a cutoff
(threshold) from the ranked scores to divide the genes
into two lists: the differentially expressed and the non-dif-
ferentially expressed genes. The genes above the threshold
are selected as differential expressions. Criteria for deter-
mining the threshold cutoff should depend on the objec-
tive of the experiment. For instance, if the objective is to
identify a small number of truly differentially expressed
genes for further study, then a stringent criterion such as
controlling either the familywise or the false discovery
error rate may be appropriate. However, if the purpose is
to determine functional relationships among genes that
have been affected by treatments or to develop a genomic
biomarker classifier, criteria that do not eliminate as many
genes may be more appropriate since the omission of
informative genes would have a much more serious con-
sequence than the inclusion of non-informative genes. In
all applications, the first step of gene ranking is the more
important of the two. Fold-change and p-value are two
common approaches to selecting differentially expressed
genes when the experiment consists of two conditions
(normal versus tumor). In the fold-change approach, a
gene is said to be differentially expressed if the ratio in
absolute value of the expression levels between the two
classes exceeds a certain threshold, e.g., a 2-fold or 3-fold
change. These genes are selected as differential expres-
sions. This approach is deficient in some aspects as it does
not account for the variability of the expression levels
among genes. For example, genes with larger variances
have a good chance of exhibiting larger fold-changes even
if they are not differentially expressed. The p-value rank-
ing is an alternative approach for gene ranking. The p-
value is the probability outcome from a statistical testing
procedure that there is no difference between two condi-
tions for an individual gene. A small p-value is evidence of
differential expressions. One common problem encoun-
tered in the use of the p-value ranking is that a gene with
small fold change can have a very small p-value (below
the p-value threshold) because of a very small standard
deviation. These two ranking criteria often result in select-
ing different lists of differentially expressed genes.
One important application in microarray experiments is
to develop a prediction model to discriminate different
biologic phenotypes or to predict the diagnostic category
or prognostic stage of a patient. Because thousands of
gene are involved, many genes are often noisy in nature
and many are irrelevant for prediction; the use of all pre-
dictors can suppress or reduce the performance of a classi-
fication algorithm. The prediction model is often based
on a selected gene set from a p-value ranking criterion
(e.g., [1]). Alternatively, genes can be ranked according to
its predictive accuracy (discriminatory ability) by per-
forming gene-by-gene prediction. The wrapper approach
is an alternative gene selection method; the wrapper
approach finds a subset of genes and evaluates its rele-
vance while building the prediction model. For example,
the classification tree (CTree) constructs a binary hierar-
chical classifier [2] through recursively partitioning parent
nodes into two child nodes. In each node, CTree searches
all possible predictors and selects the predictors that min-
imize overall true impurity. Guyon et al. [3] proposed a
recursive feature elimination (RFE) procedure for the sup-
port vector machine (SVM) classification algorithm. The
SVM-RFE method uses the magnitude as a ranking crite-
rion to select feature predictors. A strategy of applying the
wrapper approach to gene ranking is to examine the fre-
quency of selections in the cross validation [4,5]. The
most frequently selected genes are presumed to be most
relevant to the sample distinction. The gene ranking crite-
ria described above for prediction purposes would result
in different lists; also, these ranking criteria are different
from either the fold-change or p-value ranking criterion.
As discussed, there are two general objectives in gene
selection. One objective is to develop a classifier or predic-
tive model for class prediction, and the other is to identify
differentially expressed genes for a follow-up study. These
two objectives are not mutually exclusive. For example,
the set of differentially expressed genes identified presum-
ably for the second objective can be used to develop a clas-
sifier (e.g., [1,6]) for the first objective. Different gene
selection procedures often result in different rankings,
even for the same objective such as the p-value and fold-
change criteria to identify differentially expressed genes.
Because of thousands of genes involved and difficulty in
the validation, a gene ranking procedure that strikes a bal-
ance among several ordering criteria will be useful for
microarray data analysis. Furthermore, many microarray
experiments have involved two or more factors and/or
more than two experimental conditions. In the Applica-
tions section below, we consider a two-factor microarray
study to identify biological effects of radiation exposure
on gene expression. The experiment consists a control and
dose groups. The RNA samples are extracted from the con-
trol and exposed cells at 4 hours and 24 hours. Statistical
analysis would consist of a comparison between control
and dose groups to investigate the radiation effect on gene
expression, and a comparison between the two time
points to investigate the time effect. Each comparison will
result in one gene list according to the p-values from the
respective statistical test. A gene list that accounts for both
ranking criterions will be useful for investigating the most
important genes that respond to the treatment effect as
well as time effect.Page 2 of 17
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differential expressed genes is one of the most important
objectives in microarray data analysis. In a simple experi-
ment with two experimental conditions, different experi-
mental objectives or different analysis methods can
generate different lists of differentially expressed genes.
For experiments with more than two experimental condi-
tions, the analysis will generate different gene lists from
different test hypotheses.
This paper proposes three layer ranking algorithms for
gene ranking with multiple ranking criteria, where each
individual criterion constitutes its ordering of preference




The colon cancer data set [7] consists of 2000 human
genes with highest minimal intensity across 40 tumor and
22 normal colon tissue samples. A goal of a data analysis
is to select a set of genes that express differently between
the normal samples and cancer samples. We consider
three criteria to select the set of marker genes: fold-change,
p-value, and frequency of selections by the SVM-RFE clas-
sifier. The fold-change and p-value were computed for
each gene. The p-values were computed based on 100,000
permutations using the t-statistic with unequal variances.
When a tie occurs, the t-statistic is used to break the tie.
The SVM-RFE method was used to rank the discriminatory
power of a gene using a 10-fold cross-validation method.
Briefly, the entire data set was divided into 10 subsets (6
or 7 samples per subset) of roughly equal size. The SVM-
RFE was trained with a selection of 'eight' optimal genes
on the 9 (= 10-1) subsets (either 56 or 55 samples)
together and then applied to the remaining subset as the
test data set.
The classification rule is iterated 10 times to complete an
analysis of entire data set. The entire process was repeated
250 times each time the 62 samples were randomly parti-
tioned into 10 subsets. The frequency of selections for the
2000 genes over the 2500 replicates were calculated as the
3rd selection criterion.
The colon data set has been analyzed extensively by many
researchers using various gene selection and/or classifica-
tion procedures (e.g., [5,6,8,9]). The classification accu-
racy rates reported from various V-fold cross-validations,
where V = 2, 3, 5, 10, and 62, are between 70% to 89%.
The average accuracy rate in our 250 10-fold cross-valida-
tions by the SVM-RFE is 84.6% for selecting 8 genes. The
accuracy rates are 85.3% and 87.6% for selecting 16 and
32 genes, respectively. These accuracy rates are compara-
ble or better than most of reported results in the literature.
Table 1 shows the p-values (P-val), fold-change (FC), fre-
quency (FQ) and their univariate rankings for the top 50
p-value ranked genes. Note that the frequency ranking
only has 47 categories; 1926 genes have never been
selected. It can be seen that the three ranking criteria give
very different gene lists. Among those top 50 p-value
ranked genes, 29 and 21 are in the top 50 lists ranked by
the fold-change and frequency, respectively. The fold-
change and p-value rankings have a better agreement
because they both measure the fold-change except that p-
value ranking adjusts for the variability of the fold-change
across arrays.
Two-Dimensional Layer Ranking: Fold-change and p-value
The volcano plot (e.g., [10]) has been used to summarize
the two ranking schemes. The volcano plot is a plot of the
p-value (-log10p) versus fold-change (FC). The genes on
the upper left or upper right corners represent small p-
vales with large fold changes (Figure 1). On the other
hand, the genes on the upper middle have small fold-
changes, but, having small p-values, these genes will not
be on the top list by the fold-change ranking. Similarly,
the gene on the lower left or lower right have large fold-
changes, but, with larger p-values, these genes will not be
on the top list by the p-value ranking. The layer-ranking
algorithms take all these genes into account.
Applying layer ranking procedures, the numbers of layers
obtained from the point-admissible, convex, and Pareto
algorithms are 1268, 403, and 206, respectively. Table 2
lists the top 49 genes according to the point-admissible
ranking (the next layer consists of 4 genes). The three layer
rankings generally show good agreements except that
some genes may rank one layer higher or lower. Note that
the differences between two adjacent gene rankings are no
more than 2. For the 49 genes, the numbers of layers for
the point-admissible, convex, and Pareto algorithms are
26, 13, and 10, respectively. The 49 genes include all top
29 ranked genes by the fold-change ranking, top 31 by the
p-value. Table 2 shows some differences between the layer
rankings and the p-value ranking or the fold-change rank-
ing. Gene T47377, which is ranked 35th by the p-value
having a large fold-change 3.72 (rank 3rd), is ranked 8th
by the point-admissible (3rd layer) and Pareto (2nd layer)
algorithms and is ranked 6th (2nd layer) by the convex
algorithm. On the other hand, gene H08393 has a small
p-value (ranked 5th) with small fold-change 2.34 (ranked
35th), and is ranked in the 12, 11, and 10 by the three
layer algorithms.
Three-Dimensional Layer Ranking: Fold-change, p-value, and 
frequency
The numbers of layers obtained from the 3-dimensional
point-admissible, convex, and Pareto algorithms are 74,
394, and 11, respectively. The convex ranking producesPage 3 of 17
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ness of the frequency that 1926 genes (all ranked 47th)
has 0 occurrence. In general, as the dimension increases,
the number of layers decrease.
Table 3 lists the top 46 genes according to the point-
admissible ranking (the next layer consists of 6 genes). For
the 46 genes, the numbers of layers for the point-admissi-
ble, convex, and Pareto algorithms are 15, 9, and 5,
respectively. The three layer rankings generally show good
agreements. The differences between two adjacent gene
rankings are no more than 2. Similar to the 2-dimensional
layer ranking, genes that are ranked first in the one-
dimension are ranked in the first layer in the 3-dimen-
sion. The 46 genes include all top 25 ranked genes by the
univariate p-value ranking, top 25 by the fold-change, and
top 17 by the frequency. Furthermore, 39 of the 46 genes
are selected by the fold-change and p-value criteria shown
in Table 2. The other 7 genes are L11706, T51261,
H55916, J03210, U22055, H64489 and R62549, they all
have high p-values and low fold-changes, but, higher fre-
quencies.
Both gene T47377 (a larger p-value) and gene H08393 (a
smaller fold-change) discussed previously in Table 2 have
high frequencies (Table 1), both are ranked in the top 10
in Table 3. Gene D31885 and gene T86749, which are
ranked in layer #18 in Table 2, are not listed in Table 3
because of 0 frequency.
Simulation Experiment
We conducted a simulation experiment to compare the
two-dimensional (p-value and fold-change) layer rank-
ings to the univariate p-value ranking for selection of dif-
ferentially expressed genes. The top-ranked genes from the
univariate p-value ranking and the three layer rankings
were evaluated based on the false discovery rate (FDR) of
5% [11]. The experiment considered to m = 1000 genes, in
which m1 = 50 or 100 genes were differentially expressed
with a constant effect size (δ), ranging from 1.0 to 2.0 with
an increment of 0.2, as well as 2.5 and 3.0. Note that the
Table 1: One-Dimensional Ranks for Colon Data set
P-value 1–25 ranked genes P-value 26–50 ranked genes
Raw Scores Ranks Raw Scores Ranks
Gene P-v FC FQ P-v FC FQ Gene P-v FC FQ P-v FC FQ
R87126 1.0E-6 -2.89 2360 1 12 2 T57619 1.2E-4 1.70 0 26 186 47
R36977 1.0E-6 2.62 404 2 16 13 D31885 1.2E-4 2.15 0 27 28 47
M22382 2.0E-6 2.49 2 3 24 45 T86749 1.2E-4 2.27 0 28 38 47
M26383 3.0E-6 4.01 2436 4 2 1 X56597 1.2E-4 2.42 0 29 45 47
H08393 4.0E-6 2.34 2339 5 35 3 U26312 1.3E-4 2.49 0 30 25 47
X12671 5.0E-6 2.74 98 6 14 25 X55715 1.3E-4 1.86 1 31 120 46
X63629 6.0E-6 2.50 360 7 23 14 T95018 1.5E-4 1.80 0 32 139 47
M63391 9.0E-6 -3.59 1409 8 4 5 R84411 1.6E-4 2.52 62 33 20 30
Z50753 9.0E-6 -1.94 1375 9 94 6 M36981 1.7E-4 1.95 0 34 87 47
J02854 1.1E-5 -4.23 214 10 1 17 T47377 1.8E-4 3.72 290 35 3 15
H43887 1.3E-5 -3.26 88 11 6 27 U17899 1.9E-4 2.31 2 36 37 45
J50302 1.4E-5 2.62 117 12 17 22 U51023 2.0E-4 2.00 0 37 75 47
H40095 1.7E-5 2.41 2 13 29 45 T62947 2.1E-4 2.03 579 38 64 10
M36634 1.8E-5 -2.60 12 14 18 39 R42501 2.2E-4 1.84 0 39 126 47
T86473 1.9E-5 2.39 0 15 33 47 M76378 2.3E-4 -2.44 11 40 27 40
U09564 2.0E-5 2.12 0 16 50 47 T92451 2.6E-4 -3.21 2 41 8 45
U30825 2.3E-5 1.79 0 17 141 47 R64115 2.9E-4 1.98 0 42 79 47
X14958 2.5E-5 2.00 0 18 72 47 T51261 2.9E-4 2.09 1106 43 53 8
M26697 3.2E-5 2.10 0 19 52 47 X86693 3.0E-4 -3.28 1 44 5 46
X54942 4.6E-5 2.64 0 20 15 47 T61609 3.1E-4 1.71 0 45 183 47
M76378 5.3E-5 -3.24 496 21 7 12 T48804 3.4E-4 1.69 0 46 194 47
T71025 7.5E-5 -1.83 19 22 128 35 T51529 3.4E-4 1.66 0 47 211 47
T56604 8.6E-5 1.89 0 23 110 47 H55758 3.6E-4 1.76 0 48 149 47
H06524 1.0E-4 -3.09 1281 24 9 7 T58861 3.7E-4 1.81 1 49 135 46
M76383 1.0E-4 -2.52 54 25 21 31 X70326 3.8E-4 2.12 1 50 51 46
Gene ID, p-value (P-v), fold-change (FC), frequency (FQ) and their univariate ranks ordered by the p-value (t-statistic) rank for the top 50 ranked 
genes from the 2,000 genes in the colon data set. The p-values are computed based on 100,000 permutations.Page 4 of 17
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each group was 10 or 15. The data were sampled from a
normal distribution under an independent model or a
correlated model. For the correlated model, we consid-
ered a block compound symmetry (CS) correlation struc-
ture [12], in which there were 100 blocks and each block
consists of 10 dependent genes with a pairwise correlation
coefficient ρ. We assumed that the first m1/10 blocks cor-
responded to the m1 differentially expressed genes. There-
fore, the m × m variance-covariance matrix Σ of a block CS
structure for the simulation model consisted of 100 equal
blocks, and each block Σi has a CS structure with variances
of 1 and a common correlation ρ; that is,
where each Σi had an equicorrelated structure,
where ρ = 0.3 or 0.6 was the common correlation coeffi-
cient. In each array, expression data for the non-differen-
tially expressed genes in each block were generated from
the multivariate normal distribution N(0, Σi), and expres-
sion data for the differentially expressed genes in each
block were generated from the multivariate normal distri-
bution N(δ1, Σi), where 1 denoted a 10-dimensional
unity vector. For each simulated data set, the p-values and
fold changes were computed. Three layer-ranked gene lists
were then generated. The p-values were computed based
on t-statistic from 50,000 random permutations. The sim-
ulation was repeated 500 times for each combination of
m1, n, δ, and ρ.
We evaluated the same number of top ranked genes
selected by the p-value ranking and by the three layer
rankings in terms of the control of the FDR and the ability
(power) to detect differential expression. The four ranking
procedures were evaluated as follows. First, the differen-
tially expressed genes from the p-value ranking were
selected using the Benjamini and Hochberg (BH) FDR-
controlled procedure [11]. The same number of top
ranked genes, then, was selected as differentially expressed
genes for each layer ranking. For each selected gene set in
each simulation, the numbers of false positives (Vk) and
true positives (Tk) were counted, k = 1, ..., 500. The FDR
and the power were estimated by
In practice, it is possible that multiple genes are ranked in
the same layer selected for differential expression. In order
to eliminate ties and select the same number of top
ranked genes as the p-value ranking, we calculated a sec-
ondary score based on the average of ranks of - log10(p-
value) and fold-change for each gene in the last layer. We
then selected genes with the largest scores. The secondary
score is a measure that have incorporated the magnitudes
of the p-value and fold-change rankings.
Table 4 shows the estimated FDR's and powers from the
univariate p-value ranking and two-dimensional layer
rankings for the independent model (ρ = 0). The esti-
mated FDR's from the p-value ranking are generally
approximately close to the 5% significance level with sev-
eral exceptions when n = 10. In particular, the FDR is 5.4%








































































Volcano Plot for Colon Data setFigure 1
Volcano Plot for Colon Data set. Volcano plot for the 
2000 genes from the colon cancer data. The x-axis is the 
fold-change value and y axis is - log10 p-value, based on 
50,000 permutations. Using the absolute 2-fold change and p-
value 0.001 as the threshold cutoff, forty five genes in the 
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cases when δ is greater than 2 (a 4 fold-change). The esti-
mated powers from the three layer rankings are all higher
than the powers from the p-value ranking. The convex
ranking appears to perform more consistent than either
the point-admissible or Pareto ranking in maintaining the
FDR level. The FDR estimates are all below the signifi-
cance level for δ ≤ 2. The simulation results for the corre-
lated models (Tables 5 and 6) are similar to the results of
the independent model (Table 4). The estimated FDR's
from the p-value ranking are close to the significance 5%
level with few exceptions when n = 10 and δ's are small.
The convex layer ranking performs well in terms of main-
taining the FDR level.
Tables 4, 5, 6 show that all three layer rankings exhibit
higher power than the p-value ranking. However, the FDR
estimates from the Pareto ranking often exceed the signif-
icance level when δ is greater than 2. As discussed, the
point-admissible ranking generally produces the most lay-
ers, while the Pareto produces the fewest layers. Genes
with high p-value rankings or high fold-change rankings
will likely be ranked higher by the Pareto than by either
the point-admissible or convex ranking. For example, a
non-differentially expressed gene may have a large fold-
change because of a large variance. This gene is likely be
ranked higher, and be selected as differential expression
by the Pareto ranking than by the point-admissible or
convex ranking. Likewise, a differentially expressed gene is
more likely to be selected by the Pareto ranking than by
either the point-admissible or convex ranking. With
regard to the point-admissible and convex rankings, their
FDR estimates are all below the significance level when δ
≤ 2. The convex ranking gives a slightly higher power than
the point admissible ranking.
As seen in Tables 4, 5, 6, the FDR estimates from the p-
value ranking can exceed the significance level for small
effect sizes when the sample size is 10. On the other hand,
the FDR estimates from the layer rankings increase as the
effect size δ increases when the sample size is 15. In gen-
eral, when the effect sizes are large (equivalently, the sam-
ple sizes are large), the power of the t-statistic approaches
to 1. The BH procedure would select all truly differentially
expressed genes from the p-value ranking while maintain-
ing the FDR at the significance level. That is, the p-value
Table 2: Comparison of Two-Dimensional Ranking for Colon Data set
Point-Admissible top 1–25 layer ranked genes Point-Admissible top 26–49 layer ranked genes
Gene P-A Convex Pareto P-v FC Gene P-A Convex Pareto P-v FC
R87126 1 1 1 1 12 R84411 13 7 6 33 20
M26383 1 1 1 4 2 U09564 14 8 7 16 50
J02854 1 1 1 10 1 M26697 15 9 8 19 52
R36977 1 2 1 2 16 X14958 15 9 8 18 72
M63391 2 2 2 8 4 U26312 15 8 7 30 25
M22382 3 3 2 3 24 R54097 15 8 6 54 19
X12671 3 3 2 6 14 X56597 15 9 7 29 28
T47377 3 2 2 35 3 U30825 16 9 8 17 141
H43887 4 3 3 11 6 R08183 17 9 7 51 22
M76378 5 4 4 21 7 M76378 18 10 8 40 27
X86693 5 3 3 44 5 D31885 18 11 7 27 45
X63629 5 4 3 7 23 T86749 18 10 7 28 38
H08393 5 4 3 5 35 T71025 19 10 9 22 128
H06524 6 5 5 24 9 T56604 19 11 9 23 110
T92451 7 5 5 41 8 U17899 20 11 8 36 37
X54942 7 6 4 20 15 T60155 21 10 8 101 26
Z50753 8 5 4 9 94 X12466 22 11 9 53 32
J05032 8 5 4 12 17 T57619 23 12 10 26 186
M36634 9 6 5 14 18 M36981 24 12 9 34 87
M27190 10 6 6 233 10 H77597 24 11 9 86 31
T60778 10 6 6 77 11 X55715 25 13 10 31 120
H40095 11 6 5 13 29 T62947 25 12 9 38 64
L05144 12 7 7 117 13 T51023 26 13 9 37 75
M76378 13 7 6 25 21 H11084 26 12 10 83 34
T86473 13 7 6 15 33
Gene ID, point-admissible (P-A), Convex, and Pareto layer rankings, and the p-value (P-v) and fold-change (FC) rankings for the top 49 genes 
selected based on the point-admissible ranking from the 2,000 genes in the colon data set.Page 6 of 17
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control of the FDR, particularly, when the non-differen-
tially expressed genes have large variances. Finally, we do
not consider the null model of no difference between two
groups. Since the BH procedure controls the FDR, by
selecting the same number of genes the layer ranking pro-
cedures will have the FDR controlled under the null
model.
Three Applications
(1) Colon Data set
We further used the colon cancer data to illustrate a possi-
ble application of the layer ranking algorithms for
improving predictive accuracy in classification. There were
three univariate ranking criteria, three 2-dimensional
layer rankings, and one 3-dimensional layer rankings. For
each ranking criterion, the top 8, 16, and 32 ranked genes
were used for prediction using the SVM classification
(without gene selection). In order to select a pre-specified
number of genes (8, 16, or 32) the gene(s) from the last
layer was randomly selected when there are ties. For each
gene set, we used the 10-fold cross validation to estimate
predictive accuracy. Note that cross-validation performed
after gene selection process is known as internal cross-val-
idation (e.g., the SVM classifier), whereas cross-validation
prior to gene selection is known the external cross-valida-
tion [8]. For a fixed number of genes, the internal cross-
validation should have higher accuracy rates than the
external cross-validation.
Table 7 shows the predictive accuracy rates for fifteen
ordering criteria. It can be seen that (1) the more number
of genes used the higher accuracy rates can be reached; (2)
frequency criterion outperforms p-value and fold-change
criteria in general; (3) two-dimensional rankings for p-
value and fold-change in general outperforms their corre-
sponding univariate rankings; (4) two-dimensional
Pareto ranking improves prediction accuracy for fre-
quency using 16 genes.
(2) Ionizing Radiation Data set
In this example, we used the layer ranking algorithms to
identify genes that show most differentially expressed in
two experimental factors. The experiment was conducted
to study the effects of ionizing radiation-exposed human
lymphoblastoid TK6 cells on gene expression [13]. In this
Table 3: Comparison of Three-Dimensional Ranking for Colon Data set
Point-Admissible top 1–25 layer ranked genes Point-Admissible top 26–46 ranked genes
Gene P-A Convex Pareto P-v FC FQ Gene P-A Convex Pareto P-v FC FQ
R87126 1 1 1 1 12 2 H40095 9 5 4 13 29 45
M26383 1 1 1 4 2 1 H55916 9 6 4 78 47 16
J02854 1 1 1 10 1 17 L05144 10 6 5 117 13 47
R36977 1 2 1 2 16 13 M76378 10 6 4 25 21 31
M63391 2 2 2 8 4 5 R84411 10 6 4 33 20 30
T47377 2 2 2 35 3 15 J03210 10 6 5 610 584 11
M22382 3 3 2 3 24 45 R54097 11 7 4 54 19 33
X12671 3 3 2 6 14 25 T86473 12 6 5 15 33 47
M76378 3 3 3 21 7 12 T71025 12 7 4 22 128 35
H08393 3 2 2 5 35 3 U22055 12 6 5 66 69 20
H06524 3 3 3 24 9 7 U09564 13 7 5 16 50 47
H43887 4 3 3 11 6 27 M26697 13 8 5 19 52 47
X63629 4 4 2 7 23 14 X14958 13 8 5 18 72 47
Z50753 4 3 3 9 94 6 U26312 14 7 5 30 25 47
L11706 4 3 3 135 111 4 X56597 14 8 5 29 28 47
X86693 5 3 3 44 5 46 U30825 14 8 5 17 141 47
H11084 5 5 4 83 34 9 H64489 14 8 5 121 57 24
J05032 6 4 3 12 17 22 R62549 14 7 5 82 124 19
T62947 6 5 4 38 64 10 R08183 15 8 5 51 22 46
T51261 6 4 4 43 53 8 M76378 15 8 5 40 27 40
T92451 7 4 4 41 8 45 T56604 15 9 5 23 110 47
X54942 7 5 4 20 15 47
M36634 8 5 4 14 18 39
M27190 9 5 5 233 10 47
T60778 9 5 5 77 11 47
Gene ID, point-admissible (P-A), Convex, and Pareto layer rankings, and the p-value (P-v), fold-change (FC), frequency (FQ) rankings for the top 46 
genes selected based on the point-admissible ranking from the 2,000 genes in the colon data set.Page 7 of 17
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BMC Bioinformatics 2007, 8:74 http://www.biomedcentral.com/1471-2105/8/74experiment, TK6 cells were exposed to 5, 10, and 20 Gy
ionizing radiation and cultured for 4 and 24 hours after
exposure. RNA was hybridized to the Phase-1 Human-350
microarray (Phase 1 Molecular Toxicology, Santa Fe, NM)
spotted with 350 human cDNA probes. This two-color
array was designed for detection of differential expression
profiles relative to toxicological pathways. The back-
ground-subtracted intensities were normalized according
to Lowess methodology in the log2 scale, and a dye-bias
correction was applied to the resulting data, as described
in [14].
For illustrative purpose, we only used the 5 and 10 Gy ion-
izing radiation data. Statistical analysis consisted of a
comparison between the 5 and 10 Gy dose groups and a
comparison between the 4 and 24 hours after exposure. In
each comparison, the differentially expressed genes were
ranked according to the p-values using the permutation t-
test. The layer ranking algorithms were applied to both p-
value rankings. Table 8 shows the top 10 layers, according
to the point-admissible algorithm, for the three layer
rankings and the two p-value rankings, where P1 and P2
represent the ranking for the dose and time effects, respec-
tively. It can be seen that dose and time effects show two
distinct rankings. Each p-value ranking identifies a set of
genes that show differences in expression on a single bio-
logical factor. The layer rankings provide a list of 'signifi-
cant' genes that account for both dose and time effects
simultaneously. Many of the top hits have been reported
to be important in lymphoblastoid cell lines exposed to
ionizing radiation provides confidence that the analysis
produces meaningful results.
Table 4: Simulation Results for the Independent Models
FDR Power
n m1 δ P-val P-adm Convex Pareto P-val P-adm Convex Pareto
10 50 1.0 5.4 3.7 3.4 3.4 2.1 2.8 2.8 2.9
1.2 5.4 3.3 3.0 2.8 7.0 8.3 8.3 8.7
1.4 5.1 3.0 2.9 2.7 20.8 22.5 23.0 24.0
1.6 5.0 3.0 3.0 2.9 40.4 42.2 43.2 44.3
1.8 4.7 2.8 2.8 2.8 62.1 64.2 65.2 65.8
2.0 4.9 2.9 3.1 3.1 77.9 80.3 81.2 81.9
2.5 5.1 4.6 4.6 5.1 96.4 97.9 98.0 98.2
3.0 5.0 5.1 5.1 5.2 99.7 100.0 100.0 100.0
100 1.0 5.0 2.9 2.8 2.5 3.3 3.9 4.0 4.2
1.2 5.2 3.0 3.3 3.1 13.9 14.9 15.2 15.8
1.4 4.7 2.7 2.9 2.8 34.4 35.7 36.2 36.9
1.6 4.5 2.7 2.9 2.8 56.1 57.7 58.4 59.1
1.8 4.5 2.8 3.0 2.8 74.5 76.3 76.9 77.5
2.0 4.7 3.0 3.3 2.8 87.0 88.9 89.2 89.6
2.5 4.8 4.3 4.5 4.9 98.3 99.2 99.3 99.3
3.0 4.6 5.1 5.1 5.2 99.9 100.0 100.0 100.0
15 50 1.0 4.2 3.1 3.3 3.1 13.6 15.0 15.1 15.7
1.2 4.6 3.1 3.2 3.3 37.4 38.9 39.7 40.6
1.4 4.8 3.3 3.5 3.5 63.5 65.5 66.2 66.8
1.6 4.9 3.6 3.8 4.0 82.8 84.6 85.2 85.7
1.8 4.9 4.2 4.3 4.9 93.3 94.7 95.1 95.2
2.0 4.7 4.8 4.9 5.1 97.7 98.6 98.7 98.7
2.5 4.5 5.0 4.9 5.1 99.9 100.0 100.0 100.0
3.0 4.7 5.1 5.0 5.2 100.0 100.0 100.0 100.0
15 100 1.0 4.7 3.1 3.2 3.1 22.3 23.2 23.6 24.2
1.2 4.6 3.1 3.3 3.3 50.0 51.2 51.8 52.4
1.4 4.6 3.3 3.5 3.6 74.2 75.7 76.2 76.7
1.6 4.5 3.4 3.7 3.8 89.0 90.3 90.7 90.9
1.8 4.5 3.9 4.1 4.3 96.0 97.1 97.2 97.3
2.0 4.5 4.5 4.6 4.9 98.8 99.3 99.4 99.4
2.5 4.6 5.0 5.1 5.2 100.0 100.0 100.0 100.0
3.0 4.5 5.1 5.0 5.2 100.0 100.0 100.0 100.0
The average FDR and power estimates from 500 simulations at the FDR level of 5%. The same number of genes is selected using the Benjamini and 
Hochberg procedure from the p-value ranking at FDR = 5%. All values are in percentages.Page 8 of 17
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In this example, we applied the three-dimensional layer
ranking criteria to a subset of the dilution data set of Gene
Logic and the data are available at [15]. This study used
two sources of cRNA, human liver tissue and central nerv-
ous system (CNS) cell lines. Samples were hybridized to
HG-U95Av2 GeneChips arrays from Affymetrix at various
dilution and mixture levels. We considered the data from
the three concentrations 7.5, 10.0, and 20.0 μg. Five repli-
cate arrays are available for each concentration with a total
of 30 arrays. The data were extracted, normalized and
summarized using the "Affy" package from Bioconductor.
For preprocessing methods, we used MAS 5.0 for back-
ground correction and PM correction, the quantile nor-
malization method for normalization of the probe level,
and the RMA method for summarization of probe inten-
sities, which was suggested by [16].
Since the two samples are biologically distinct, it is
expected that many genes will show differential expres-
sions between the two samples. The relative abundance of
each gene is proportional to its dilution concentration.
However, the expression ratios between the pure samples
(fold changes) are relative and should not vary with the
amount of cRNA. If a gene expresses differently between
the liver and CNS samples at 20.0 μg concentration, then
we expect the same gene would show a difference in
expression at other concentrations. In this application, the
layer ranking algorithm is used to provide a ranking sys-
tem from a long list of differentially expressed genes gen-
erated from three dilution concentrations.
The liver and CNS samples were compared for each of the
three concentrations using the SAM procedure [17]. The
level of significance was set at the false discovery rate of
Table 5: Simulation Results for the Correlated Models with ρ = 0.3
FDR Power
n m1 δ P-val P-adm Convex Pareto P-val P-adm Convex Pareto
10 50 1.0 4.9 3.2 3.1 3.0 2.2 3.0 2.9 3.0
1.2 5.3 3.4 3.1 3.1 7.7 9.0 9.1 9.5
1.4 4.8 2.8 2.8 2.7 20.3 21.9 22.4 23.1
1.6 5.2 3.1 3.2 3.0 41.0 43.1 43.9 44.9
1.8 4.7 2.8 3.0 2.9 61.3 63.6 64.3 65.3
2.0 4.9 3.0 3.2 3.3 77.4 79.9 80.5 81.2
2.5 4.9 4.5 4.6 4.9 96.4 97.9 98.0 98.1
3.0 4.7 5.0 4.9 5.1 99.7 99.9 99.9 99.9
100 1.0 4.6 3.0 2.8 3.0 3.8 4.5 4.5 4.7
1.2 5.1 2.6 2.6 2.6 14.1 15.1 15.4 16.0
1.4 4.7 2.8 3.0 2.9 33.1 34.3 34.9 35.6
1.6 4.8 2.8 3.0 3.0 56.7 58.3 59.0 59.6
1.8 4.5 2.8 2.9 2.9 74.5 76.3 76.9 77.4
2.0 4.6 3.1 3.3 3.3 86.6 88.4 88.8 89.2
2.5 4.5 4.2 4.4 4.7 98.4 99.2 99.3 99.3
3.0 4.6 5.0 5.0 5.2 99.9 100.0 100.0 100.0
15 50 1.0 5.0 4.0 3.7 3.8 13.7 14.9 15.2 15.6
1.2 4.8 3.3 3.4 3.5 36.7 38.3 38.9 39.6
1.4 4.5 3.1 3.3 3.3 61.5 63.3 64.0 64.8
1.6 4.8 3.6 3.7 3.9 82.3 84.0 84.8 85.1
1.8 4.9 4.2 4.4 4.7 93.1 94.4 94.9 94.9
2.0 4.8 5.0 5.0 5.4 97.6 98.5 98.5 98.6
2.5 4.5 4.8 4.7 5.1 99.9 100.0 100.0 100.0
3.0 4.7 5.1 4.9 5.2 100.0 100.0 100.0 100.0
15 100 1.0 4.6 3.3 3.2 3.2 22.5 23.4 23.9 24.5
1.2 4.4 3.1 3.3 3.3 49.6 50.7 51.4 51.8
1.4 4.6 3.2 3.5 3.4 74.0 75.5 75.9 76.3
1.6 4.3 3.3 3.5 3.6 89.0 90.3 90.6 90.9
1.8 4.5 4.1 4.3 4.6 96.1 97.0 97.1 97.2
2.0 4.5 4.5 4.6 4.9 98.9 99.4 99.4 99.4
2.5 4.4 5.1 5.1 5.2 100.0 100.0 100.0 100.0
3.0 4.4 5.1 5.1 5.2 100.0 100.0 100.0 100.0
The average FDR and power estimates are same as in Table 4.Page 9 of 17
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expressed genes identified from the concentrations 20.0,
10.0, and 7.5 μg, respectively. Figure 2 summaries the
number of differentially expressed genes selected from the
three comparisons. The overlapping regions denote the
number of genes that were differentially expressed in two
or all three concentration concentrations. There were
1034 genes which show consistently differential expres-
sions in the two RNA samples in all three concentrations.
We then applied the three-dimensional convex layer rank-
ing algorithm to three p-value lists obtained from the SAM
procedure. Ninety-five layers were obtained. The layer
rankings of 1034 differentially expressed genes are shown
in Figure 3. The other two layer ranking algorithms yield
similar results (data not shown).
Table 9 provides the Kenall's τ correlation matrix of the p-
value rankings of 1034 genes for the three concentrations
with the three proposed three-dimensional layer rankings.
Ideally, the p-value rankings of the 1034 genes identified
as changes in expression between the liver and CNS sam-
ples should have high agreement across the three RNA
concentrations. It is apparent that there are many discord-
ances among the 20 μg 10 μg, and 7.5 μg p-value rankings
(Figure 3 and Table 9). In contrast, the three layer ranking
algorithms improve the comparability (Table 9); they pro-
vide compromising gene rankings by combining informa-
tion across the three RNA concentrations. The layer
ranking algorithms can help an investigator to pick a few
of top-ranked genes with confidence across multiple list-
ings for further investigation.
Discussion and Conclusion
Recently, the MicroArray Quality Control consortium sug-
gested: "Fold-change ranking plus a non-stringent P-value
cutoff can be used as a baseline practice for generating
Table 6: Simulation Results for the Correlated Models with ρ = 0.6
FDR Power
n m1 δ P-val P-adm Convex Pareto P-val P-adm Convex Pareto
10 50 1.0 4.2 3.0 2.8 2.7 2.5 3.0 3.1 3.2
1.2 4.1 3.2 3.1 3.1 8.3 9.4 9.4 9.8
1.4 5.5 3.1 3.1 3.0 22.0 23.6 24.1 24.8
1.6 5.1 3.2 3.2 3.1 39.3 41.2 41.9 42.7
1.8 5.0 3.1 3.2 3.2 61.9 64.0 64.9 65.7
2.0 5.0 3.3 3.5 3.7 77.6 79.7 80.3 81.0
2.5 4.5 4.4 4.4 4.8 96.1 97.2 97.4 97.5
3.0 4.5 5.0 5.0 5.1 99.7 99.8 99.9 99.9
100 1.0 5.2 3.6 3.1 3.2 4.4 5.1 5.1 5.3
1.2 4.2 2.5 2.6 2.5 14.4 15.3 15.6 16.1
1.4 3.9 2.4 2.5 2.4 32.2 33.5 34.0 34.7
1.6 4.7 2.9 3.0 3.0 55.9 57.5 58.1 58.7
1.8 4.5 2.9 3.1 3.1 73.8 75.4 76.0 76.5
2.0 4.4 2.9 3.2 3.2 86.0 87.7 88.2 88.4
2.5 4.5 4.4 4.6 4.9 98.4 99.1 99.2 99.2
3.0 4.5 4.8 4.8 5.1 99.9 100.0 100.0 100.0
15 50 1.0 5.1 3.7 3.7 3.8 15.5 16.6 16.9 17.3
1.2 4.7 3.3 3.5 3.5 36.6 38.3 38.8 39.6
1.4 4.6 3.3 3.4 3.6 61.7 63.6 64.3 64.8
1.6 4.8 3.6 3.6 4.0 81.2 83.1 83.5 83.9
1.8 4.5 4.0 4.2 4.4 92.6 93.8 94.1 94.3
2.0 4.6 4.8 4.9 5.1 97.5 98.2 98.3 98.3
2.5 4.8 5.1 5.0 5.3 100.0 100.0 100.0 100.0
3.0 4.8 5.2 5.0 5.3 100.0 100.0 100.0 100.0
100 1.0 4.3 2.9 2.9 2.9 23.2 24.1 24.5 24.9
1.2 4.3 3.3 3.4 3.4 49.4 50.4 51.0 51.6
1.4 4.6 3.5 3.7 3.7 73.7 75.0 75.6 76.0
1.6 4.3 3.3 3.6 3.7 89.1 90.4 90.6 90.9
1.8 4.5 4.1 4.2 4.4 95.8 96.7 96.8 96.9
2.0 4.6 4.7 4.8 5.1 98.8 99.2 99.3 99.3
2.5 4.4 5.1 5.0 5.2 100.0 100.0 100.0 100.0
3.0 4.6 5.2 5.1 5.3 100.0 100.0 100.0 100.0
The average FDR and power estimates are same as in Table 4.Page 10 of 17
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researchers have questioned this approach [19]. The p-
value ranking ensures the control of significance level,
while the fold-change ranking may provide a better rank-
ing when sample size (or effect size) is small. The layer-
ranking algorithms provide a gene list that reconciles the
p-value and fold-change rankings implied by the volcano
plot. The simulation shows that for experiments with
small or moderate sample sizes (less than 20 per group)
and detecting a 4-fold change or less, the layer ranking
selects differentially expressed genes with generally lower
FDR and higher power than the p-value ranking. For large
sample sizes or effect sizes, the p-value ranking will out-
perform the layer rankings.
We illustrate three additional applications of the layer
ranking algorithms. In the colon data example, we illus-
trate an application of using layer rankings for improving
predictive accuracy. Because of a large number of genes
involved, the gene selection becomes one of the most
important steps in the development of a prediction
model. An analysis by Michiels et al. [20] showed that the
list of genes identified as predictors of cancer prognosis
was highly unstable. The selected gene set strongly
depended on the selected patients in the training set. In
this example, we consider the three gene selection criteria:
p-value, fold-change, and frequency of selections. Table 8
indicates that the improvement of predictive accuracy of
the layer rankings over the p-value rankings appears mar-
ginal. The simulation indicates that when the sample size
is large, the layer rankings can exceed the significant level.
This may not be a problem for prediction purposes, since
the omission of informative genes generally has a much
more serious consequence on predictive accuracy than the
inclusion of non-informative genes. We are currently
investigating different univariate selection criteria in con-
junction with layer ranking algorithms to improve predic-
tive accuracy. In general, the p-value can be calculated in
many different ways such as the parametric t-test, permu-
tation t-test, or SAM method. Frequency of selections can
be calculated by other classification algorithms such as
CTree [2] or Random Forest [21]. In addition, instead of
selecting 8 optimal genes in each cross validation, we may
select 64 genes or more so that each gene has higher prob-
Table 7: Classification Results for Colon Data set
Number of Genes
Ranking 8 16 32
Univariate (One-Dimensional) Ranking
P-value (P-val) 84.4 88.8 88.6
Fold-Change (FC) 86.9 87.3 88.5
Frequency (Freq) 89.6 89.9 91.9
Two-Dimensional Ranking
P-val & FC (1) 88.7 88.8 90.0
P-val & FC (2) 88.7 88.7 88.8
P-val & FC (3) 86.6 88.7 88.7
P-val & Freq (1) 88.9 89.7 89.9
P-val & Freq (2) 89.1 86.7 90.5
P-val & Freq (3) 89.8 90.4 90.6
FC & Freq (1) 88.3 89.9 91.4
FC & Freq (2) 87.2 88.1 91.9
FC & Freq (3) 88.7 90.0 91.5
Three-Dimensional Ranking
P-val & FC & Freq (1) 86.3 89.0 90.3
P-val & FC & Freq (2) 88.4 89.1 89.8
P-val & FC & Freq (3) 88.7 86.7 90.5
Gene ID, p-value, fold-change, and the layer assigned by the (1) point-admissible, (2) convex, and (3) Pareto algorithms for 70 genes selected based 
on the p-value 0.001 and 2.0-fold as the cutoff from the 2,000 genes in the colon data set. The p-values are computed based on 50,000 
permutations.Page 11 of 17
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BMC Bioinformatics 2007, 8:74 http://www.biomedcentral.com/1471-2105/8/74ability been selected. Those genes that have never been
selected are unlikely to be differentially expressed. The 2-
dimensional p-value and frequency layer rankings may be
useful to filter out a small number of non-differentially
expressed genes. The genes in the bottom layers may be
the candidates for filtering out.
In the ionizing radiation example, we apply the layer
ranking algorithms to a two-factor experiment. The algo-
rithms can be used in the one-factor experiment with
more than two conditions. Consider an experiment to
study effect of p53 genotype on gene expression profiles.
The experiment consists of three mouse genotypes: wild-
type (+/+), knock-out (-/-), and heterozygous (+/-). Statis-
tical analysis typically consists of a comparison among the
three genotypes. A gene list ranked according the p-values
from the F-statistic can be obtained using either permuta-
tion or parametric approach. An important follow-up
analysis is the comparisons between the knout-out and
wild-type mouse and between the heterozygous and wild-
type mouse. The Dunnett's test is frequently used to gen-
erate the differentially expressed gene lists for the two
comparisons. However, the investigator is often interested
in the genes that show differences in both comparisons.
(Note that the significant genes identified in the F-test
may be insignificant in both Dunnett's tests.) One
approach is to select the genes that are significant in both
gene lists at a given p-value cutoff. However, when the
number of common genes is large, the investigator must
select a subset of genes from the two criteria (the dilution
example). The layer ranking algorithm can be used to pro-
vide a list of the most "important" genes that account for
both objectives simultaneously for follow-up investiga-
tion. In the dilution example, we illustrate the strength of
the three-dimensional layer ranking algorithms for com-
bining discordant results derived from three concentra-
tion groups. The set of probes that are consistently
identified at different RNA concentrations is ranked
Table 8: Rankings on two p-values for Ionizing Radiation Data set
Gene name P-A Convex Pareto P1 P2
Carcinoembryonic antigen (CD66e) 1 1 1 2 22
Gadd45 1 1 1 1 262
Glucose-6-phosphate dehydrogenase 1 1 1 12 2
p55CDC 1 1 1 3 10
Uncoupling protein-2 1 1 1 55 1
Heat shock protein-90 2 3 3 30 5
RAD 51 homologue 2 2 2 14 8
RANTES 2 2 2 4 14
Phenol sulfotransferase 3 2 2 96 3
Glutathione peroxidase 4 4 4 45 9
Pim1 proto-oncogene 4 3 3 127 4
SSAT 4 3 3 6 23
Transthyretin 4 3 3 5 60
Transferrin 5 6 6 29 21
Biliary glycoprotein 6 6 6 10 151
Casein kinase 1 delta 6 5 5 8 177
Interferon stimulatory gene factor-3 6 4 4 178 6
Plasminogen activator inhibitor-2 6 4 4 13 31
c-jun 7 6 6 9 255
Carnitine palmitoyl-CoA transferase 7 5 5 95 12
Heme oxygenase-1 7 5 5 318 7
Multidrug resistant protein-1 7 4 4 7 274
Neurofibromin (NF1 tumor suppressor) 7 5 5 19 29
Connexin-40 8 6 6 16 58
STAT-3 8 8 8 80 17
Activating transcription factor-3 9 8 8 20 47
Cell division cycle protein-25 9 6 6 174 11
Hypoxanthine-guanine phosphoribosyltransferase 9 7 7 23 36
S-adenosylmethionine decarboxylase 9 7 7 32 25
Alpha-1 acid glycoprotein 10 9 9 18 90
Bcl-xL 10 7 7 148 13
FosB 10 7 7 103 15
Tryptophanyl-tRNA synthetase 10 8 8 27 38
Gene name, point-admissible (P-A), Convex, and Pareto layer rankings, and the p-value (P1 and P2) rankings for the top 33 genes selected based on 
the point-admissible ranking from the 350 genes in the ionizing radiation data set.Page 12 of 17
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BMC Bioinformatics 2007, 8:74 http://www.biomedcentral.com/1471-2105/8/74according to compatibility between differential expres-
sion profiles in three concentration groups.
In summary, a microarray experiment can generate differ-
ent gene lists by different filter, normalization, or analysis
methods for different study objectives. The layer ranking
algorithm can be useful to help investigators to select the
most promising genes from multiple gene lists.
Methods
Let S = {pi = (xi, yi) | i = 1,..., m} denote the set of points
under consideration, where xi > 0. For example, x is the
Results of Dilution Data SetFig re 2
Results of Dilution Data Set. Venn diagram of the dilution data set demonstrating the agreement in the number of differen-
tially expressed genes selected from the three concentrations using SAM procedure at the 0.01 FDR level.
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BMC Bioinformatics 2007, 8:74 http://www.biomedcentral.com/1471-2105/8/74fold change in absolute value and y is (-log10 p). Barndorff-
Nielsen and Sobel [22] proposed a layer ranking criterion
for ordering multivariate data. The layer ranking divides S
into disjoint sets (layers) of different ranks, the points in
the same layer have the same rank. In this paper, we
present three layer ranking criteria based on the principle
of the first quadrant-admissible [22]. A point, pi = (xi, yi),
is called first quadrant-admissible in S if there does not
exist any point p = (x, y) such that x > xi and y > yi. Con-
versely, a point, pi = (xi, yi), is dominated by another point
pj in S if (xi <xj and yi ≤ yj) or (xi ≤ xj and yi <yj). Three layer
ranking algorithms are described below.
3D convex layer ranking for Dilution Data SetFigure 3
3D convex layer ranking for Dilution Data Set. Scatter plot of three p-value lists for the 1034 differentially expressed 
genes selected from Figure 2. Colors represent the layers of genes identified by the three-dimensional convex layer ranking 
algorithm.
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A point (xi, yi) is called r-th layer (first quadrant) admissi-
ble (r = 1,2, ...) [22] if there are exactly (r - 1) points (x, y)
such that x > xi and y > yi. Let Sr denote the set of r-th layer
admissible (r = 1, 2,...). Each observation is either r-th
layer admissible (r = 1, 2, ...) or inadmissible; that is, S =
S1 ∪ S2 ∪ ... . For each point pi = (xi, yi) in S, let r denote
the number of points p = (x, y)'s for which x > xi and y > yi.
The point pi is assigned to the (r + l)-th layer (r = 0,1,...).
Line-admissible (convex) layer
A line segment is called (first quadrant) admissible in S if
every point on the line segment is first quadrant-admissi-
ble in S. The 1-st line-admissible layer is obtained by find-
ing the admissible points that are connected by line(s)
with non-positive or infinite slopes (the minimum convex
set). The r-th layer is obtained similarly by stripping off
the points on the (r - 1)-th layers (r = 2, 3...).
Pareto layer
The Pareto layer (front) was introduced by [23] for gene
ranking. The 1-st Pareto layer consists of all points not
dominated by other points. The r-th layer is obtained sim-
ilarly by striping off the points on the (r - l)-th layers (r =
2, 3...).
The three layer ranking algorithms are illustrated in Figure
4. Figure 4(a) consists of 15 points (a-o). In the point
admissible layer ranking, for a given point, say, l, the
number of points with both coordinates greater than l
(the number of points in the upper right) is 7. The point l
is assigned to the 8-th layer (Figure 4(b)). Note that the
point admissible layer may have empty layers, for example,
4-th and 5-th layers. Figures 4(c) and 4(d) show the line-
admissible layers and Pareto layers, respectively. In Figure
4(c), all line segments have negative slopes. The point e is
dominated by the line segment connected points c and d.
Therefore, e is assigned to the next (3-rd) layer. In Figure
4(d), e has a larger x-coordinate than c, and a larger y-
coordinate than d. Therefore, e is not dominated by c or d;
and c, d, and e are all assigned to the 2-nd layer. The sub-
scripts in Figure 4(a) represent layers for which the point
is assigned by the three algorithms. For example, the point
n has the subscript 865 indicating that n is assigned to the
8th, 6th and 5th layers by the point-admissible, convex,
and Pareto algorithms, respectively. Note that the empty
layers for the r-th layer algorithm are removed and the
non-empty layers are renumbered. The numbers of layers
for the three ranking algorithms are 9, 7, and 6 (point o).
For continuous measurements such as fold-change or p-
value, the point-admissible ranking generally produces the
most layers, while the Pareto ranking produces the fewest
layers.
Extending the previous point-admissible layer and Pareto
layer to three or more dimensional situations is straight-
forward. For three-dimensional examples, a point pi = (xi,
yi, zi) is assigned to the (r + 1)-th layer if there are r points
p = (x, y, z)'s such that x > xi, y > yi, and z > zi. Similarly, a
point pi = (xi, yi, zi) belongs to the 1-st Pareto layer if no
other points dominate it, i.e.,
{(x, y, z)|x ≥ xi, y ≥ yi, z ≥ zi}\{(x, y, z)|x = xi, y = yi, z = zi}
is the null set. Then points are assigned to the r-th Pareto
layer (r = 2,3,...) recursively in the same way by striping off
the points on the 1-st,...,(r-1)-th layers.
To find a higher-dimensional convex layer, an algorithm
for determining the convex polytope (convex hull in an
arbitrary dimension) is needed and interested readers are
referred to Chapter 11 of [24]. One popular implementa-
tion can also be found at [25]. The 1-st convex layer is
obtained as the intersection of the points lying on the con-
vex polytope and on the 1-st Pareto layer. The next step is
to recursively strip off the points on the 1-st,..,(r-1)-th lay-
ers, and points are assigned to the r-th convex layer (r =
2,3,...) if they lie on the resultant convex polytope and on
the resultant 1-st Pareto layer.
Table 9: Kendall's τ correlation among six rankings
20.0 μg 10.0 μg 7.5 μg P-A Convex Pareto
20.0 μg 1.000
10.0 μg 0.695 1.000
7.5 μg 0.660 0.669 1.000
P-A 0.776 0.794 0.812 1.000
Convex 0.765 0.789 0.824 0.978 1.000
Pareto 0.769 0.794 0.825 0.978 0.985 1.000
Kendall's τ correlation matrix among six rankings, three p-value rankings from three concentrations and three three-dimensional layer rankings, for 
the 1034 genes showing consistenly differential expression in all three concentrations in the Dilution data set.Page 15 of 17
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Three Ranking MethodsFigure 4
Three Ranking Methods. Illustration of three layer ranking algorithms for 15 points. (a) Fifteen data points (a-o) on a two-
dimensional space. The subscripts represent the layers for which the point is assigned by the three algorithms. For example, 
the subscript 865 indicates that point n is assigned to 8th, 6th and 5th layers for (b) Point-admissible algorithm, (c) Convex 
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A multiple ordering procedure for gene selection written
in R with various options is freely available.
Project name: multiple ordering gene selection
Project home page: http://gap.stat.sinica.edu.tw/Soft
ware/mvo.R
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